237 related articles for article (PubMed ID: 34407984)
1. Targeted regulation of transcription in primary cells using CRISPRa and CRISPRi.
Jensen TI; Mikkelsen NS; Gao Z; Foßelteder J; Pabst G; Axelgaard E; Laustsen A; König S; Reinisch A; Bak RO
Genome Res; 2021 Nov; 31(11):2120-2130. PubMed ID: 34407984
[TBL] [Abstract][Full Text] [Related]
2. Targeted Modulation of Chicken Genes In Vitro Using CRISPRa and CRISPRi Toolkit.
Chapman B; Han JH; Lee HJ; Ruud I; Kim TH
Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107664
[TBL] [Abstract][Full Text] [Related]
3. CRISPR Interference and Activation to Modulate Transcription in Yarrowia lipolytica.
Misa J; Schwartz C
Methods Mol Biol; 2021; 2307():95-109. PubMed ID: 33847984
[TBL] [Abstract][Full Text] [Related]
4. CRISPR-Cas-mediated transcriptional modulation: The therapeutic promises of CRISPRa and CRISPRi.
Bendixen L; Jensen TI; Bak RO
Mol Ther; 2023 Jul; 31(7):1920-1937. PubMed ID: 36964659
[TBL] [Abstract][Full Text] [Related]
5. Systematic Evaluation of CRISPRa and CRISPRi Modalities Enables Development of a Multiplexed, Orthogonal Gene Activation and Repression System.
Martella A; Firth M; Taylor BJM; Göppert A; Cuomo EM; Roth RG; Dickson AJ; Fisher DI
ACS Synth Biol; 2019 Sep; 8(9):1998-2006. PubMed ID: 31398008
[TBL] [Abstract][Full Text] [Related]
6. A multiplexed gRNA piggyBac transposon system facilitates efficient induction of CRISPRi and CRISPRa in human pluripotent stem cells.
Hazelbaker DZ; Beccard A; Angelini G; Mazzucato P; Messana A; Lam D; Eggan K; Barrett LE
Sci Rep; 2020 Jan; 10(1):635. PubMed ID: 31959800
[TBL] [Abstract][Full Text] [Related]
7. CRISPRi and CRISPRa Screens in Mammalian Cells for Precision Biology and Medicine.
Kampmann M
ACS Chem Biol; 2018 Feb; 13(2):406-416. PubMed ID: 29035510
[TBL] [Abstract][Full Text] [Related]
8. CRISPR technologies for stem cell engineering and regenerative medicine.
Hsu MN; Chang YH; Truong VA; Lai PL; Nguyen TKN; Hu YC
Biotechnol Adv; 2019 Dec; 37(8):107447. PubMed ID: 31513841
[TBL] [Abstract][Full Text] [Related]
9. Chemical Modification of Guide RNAs for Improved CRISPR Activity in CD34+ Human Hematopoietic Stem and Progenitor Cells.
Shapiro J; Tovin A; Iancu O; Allen D; Hendel A
Methods Mol Biol; 2021; 2162():37-48. PubMed ID: 32926376
[TBL] [Abstract][Full Text] [Related]
10. CRISPR-mediated transcriptional activation with synthetic guide RNA.
Strezoska Ž; Dickerson SM; Maksimova E; Chou E; Gross MM; Hemphill K; Hardcastle T; Perkett M; Stombaugh J; Miller GW; Anderson EM; Vermeulen A; Smith AVB
J Biotechnol; 2020 Aug; 319():25-35. PubMed ID: 32470463
[TBL] [Abstract][Full Text] [Related]
11. Modulating Gene Expression in Epstein-Barr Virus (EBV)-Positive B Cell Lines with CRISPRa and CRISPRi.
Wang LW; Trudeau SJ; Wang C; Gerdt C; Jiang S; Zhao B; Gewurz BE
Curr Protoc Mol Biol; 2018 Jan; 121():31.13.1-31.13.18. PubMed ID: 29337370
[TBL] [Abstract][Full Text] [Related]
12. CRISPR/dCas system as the modulator of gene expression.
Kazi TA; Biswas SR
Prog Mol Biol Transl Sci; 2021; 178():99-122. PubMed ID: 33685602
[TBL] [Abstract][Full Text] [Related]
13. Recent Progress and Future Prospect of CRISPR/Cas-Derived Transcription Activation (CRISPRa) System in Plants.
Ding X; Yu L; Chen L; Li Y; Zhang J; Sheng H; Ren Z; Li Y; Yu X; Jin S; Cao J
Cells; 2022 Sep; 11(19):. PubMed ID: 36231007
[TBL] [Abstract][Full Text] [Related]
14. Toward tunable dynamic repression using CRISPRi.
Jang S; Jang S; Jung GY
Biotechnol J; 2018 Sep; 13(9):e1800152. PubMed ID: 29714047
[TBL] [Abstract][Full Text] [Related]
15. CRISPR Interference (CRISPRi) and CRISPR Activation (CRISPRa) to Explore the Oncogenic lncRNA Network.
Morelli E; Gulla' A; Amodio N; Taiana E; Neri A; Fulciniti M; Munshi NC
Methods Mol Biol; 2021; 2348():189-204. PubMed ID: 34160808
[TBL] [Abstract][Full Text] [Related]
16. Compact and highly active next-generation libraries for CRISPR-mediated gene repression and activation.
Horlbeck MA; Gilbert LA; Villalta JE; Adamson B; Pak RA; Chen Y; Fields AP; Park CY; Corn JE; Kampmann M; Weissman JS
Elife; 2016 Sep; 5():. PubMed ID: 27661255
[TBL] [Abstract][Full Text] [Related]
17. Engineered CRISPRa enables programmable eukaryote-like gene activation in bacteria.
Liu Y; Wan X; Wang B
Nat Commun; 2019 Aug; 10(1):3693. PubMed ID: 31451697
[TBL] [Abstract][Full Text] [Related]
18. Genome editing in human hematopoietic stem and progenitor cells via CRISPR-Cas9-mediated homology-independent targeted integration.
Bloomer H; Smith RH; Hakami W; Larochelle A
Mol Ther; 2021 Apr; 29(4):1611-1624. PubMed ID: 33309880
[TBL] [Abstract][Full Text] [Related]
19. Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells.
Hendel A; Bak RO; Clark JT; Kennedy AB; Ryan DE; Roy S; Steinfeld I; Lunstad BD; Kaiser RJ; Wilkens AB; Bacchetta R; Tsalenko A; Dellinger D; Bruhn L; Porteus MH
Nat Biotechnol; 2015 Sep; 33(9):985-989. PubMed ID: 26121415
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional regulation by CRISPR/dCas9 in common wheat.
Zhou H; Xu L; Li F; Li Y
Gene; 2022 Jan; 807():145919. PubMed ID: 34454034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
